| Name | Discount Drug Mart # 01 |
|---|---|
| Organization Name | Discount Drug Mart Inc |
| Location | 500 Abbe Rd N, Elyria, Ohio 44035 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (440) 365-8319 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new tool - the Edmonton obesity staging system (EOSS) - improves on current methods to predict the risk of death in overweight and obese people, according to a study in CMAJ.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
The monoclonal antibody elotuzumab has been approved in combination with lenalidomide and dexamethasone since May 2016 for further treatment of multiple myeloma in adults who have received at least one previous treatment.
› Verified 9 days ago
| NPI Number | 1225074321 |
| Organization Name | DISCOUNT DRUG MART INC |
| Doing Business As | DISCOUNT DRUG MART |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 500 Abbe Rd N, Elyria, OH 44035 |
| Phone Number | 440-365-8319 |
News Archive
A new tool - the Edmonton obesity staging system (EOSS) - improves on current methods to predict the risk of death in overweight and obese people, according to a study in CMAJ.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
The monoclonal antibody elotuzumab has been approved in combination with lenalidomide and dexamethasone since May 2016 for further treatment of multiple myeloma in adults who have received at least one previous treatment.
› Verified 9 days ago
News Archive
A new tool - the Edmonton obesity staging system (EOSS) - improves on current methods to predict the risk of death in overweight and obese people, according to a study in CMAJ.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
The monoclonal antibody elotuzumab has been approved in combination with lenalidomide and dexamethasone since May 2016 for further treatment of multiple myeloma in adults who have received at least one previous treatment.
› Verified 9 days ago
Giant Eagle Pharmacy #6375 Type: Community/Retail Pharmacy Location: 320 Market Dr, Elyria, Ohio 44035 Phone: (440) 324-1742 | |
Cvs Pharmacy #03997 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 443 Cleveland St, Elyria, Ohio 44035 Phone: (440) 365-7162 | |
Rite Aid Pharmacy 04245 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 142 Broad St, Elyria, Ohio 44035 Phone: (440) 322-7780 | |
Cvs Pharmacy #16570 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 240 Market Dr, Elyria, Ohio 44035 Phone: (440) 324-2339 | |
Walgreens #5138 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 100 Cleveland St, Elyria, Ohio 44035 Phone: (440) 322-7604 |